Mahatma Gandhi Mission Medical College and Hospital is located in Navi Mumbai, Maharashtra, India. It was established in 1989 and granted Deemed University status in 2006.
Survodutide represents an innovative approach to obesity management and metabolic-associated fatty liver disease (MAFLD). These conditions, often closely linked with type 2 diabetes (T2DM) and cardiovascular diseases, demand effective treatment strategies. Survodutide acts by targeting both GLP-1 and glucagon receptors. This new dual agonist offers potential transformative benefits, with early clinical trials showcasing significant weight loss and improvements in metabolic markers. Survodutide's mechanism of action includes appetite regulation, enhanced glucose metabolism, and increased energy expenditure, making it a promising option for those struggling with obesity and related health issues. This review assesses Survodutide's pharmacology, efficacy, and safety in MASH and obesity, while also outlining its broader metabolic and cardiovascular benefits. It compares Survodutide's dual-agonist mechanism and clinical performance with single-target incretin therapies to clarify its potential role in the evolving treatment landscape. While the initial results are promising, the review emphasizes the importance of continued research to fully understand Survodutide's long-term safety and effectiveness. Ongoing trials will provide critical insights into its overall impact, side effects, patient response, and cost considerations. This article highlights Survodutide's potential in the treatment of obesity and metabolic disordersand evaluates its place in therapy for seeking improved outcomes.
Background: Alzheimer’s disease (AD) is a leading cause of dementia, with a rapidly increasing burden in India. Although pharmacotherapy can halt disease development, treatment is mostly out-of-pocket, making drug affordability a key concern. Wide pricing disparities between branded generics may further impede access and adherence. The study objective of this study was to evaluate inter-brand cost variation among anti-Alzheimer drugs available in the Indian pharmaceutical market. Methods: A cross-sectional pharmacoeconomic analysis was conducted by using the data obtained from the Current Index of Medical Specialties (CIMS) and MIMS website. Commonly prescribed drugs such as donepezil, rivastigmine, memantine, and their combinations were analyzed. Cost ratio and percentage of cost variation were calculated for each formulation. Results: Prices varied significantly across all medicines. Rivastigmine displayed the most fluctuation, especially in 1.5 mg capsules (1634.13%; price ratio 17.34). Memantine 10 mg pills varied by 364.72%, whilst donepezil exhibited a lower but still considerable variance, with a maximum of 120.44%. Fixed-dose combinations showed moderate variability, with the largest being donepezil 5 mg plus memantine 5 mg (117.44%). Substantial discrepancies between the top and lowest expensive brands emphasize the possibility of cost savings. Conclusion: Significant inter-brand price disparities exist among anti-Alzheimer medications in India, with rivastigmine showing the highest variability, followed by memantine and donepezil. Promoting cost-conscious prescribing and the use of lower-priced, bioequivalent alternatives could reduce economic burden and improve treatment continuity in patients with AD.
Abstract Objective: Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality worldwide with India alone contributing nearly 27% of the global PTB burden. Although alterations in the vaginal microbiome have been implicated in PTB its association in the Indian context is underemployed. This study aimed to investigate the association of vaginal microbiome and PTB in Indian women at the time of delivery. Study design: The vaginal swabs were collected at the time of delivery from 72 women (31 term 41 preterm) admitted to a tertiary care hospital in Western India. Microbial DNA was extracted and the V3 V4 region of the 16S rRNA gene was sequenced. Community composition alpha and beta diversity and differential taxonomic abundance were assessed using bioinformatics pipelines. Results: At the time of delivery there were no significant differences in alpha or beta diversity between term and preterm groups. Principal coordinate and unsupervised clustering analyses showed no group wise segregation. The relative abundance of individual Lactobacillus species including L. iners and L. helveticus did not differ significantly between the two groups. However a modest difference in the relative abundance of Streptococcus was observed between the two groups after adjustment. Conclusion: This study found no major microbial shifts in the vaginal microbiome associated with preterm birth in this cross sectional cohort of Indian women suggesting that vaginal dysbiosis at the time of delivery may not be a principal driver of PTB in this population. These findings underscore the need for larger longitudinal and ethnically diverse studies using standardized methodologies better to understand the microbiomes role in PTB risk. Key Words: Prematurity Lactobacillus Streptococcus bacteria association ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study is not receive any funding ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by the Human Ethics Committee of MGM Institute of Health Sciences (MGMIHS), Kamothe, Navi Mumbai (Approval No: MGMIHS/RES/02/2020-21/401A). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data produce in the study are contained in the manuscript
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Despite being preventable and treatable, poor awareness and knowledge of COPD pose a critical barrier to disease prevention and early diagnosis. Previous research has confirmed a paucity of disease awareness in healthcare professionals and patients, particularly in low- and middle-income countries. This systematic review assessed awareness and knowledge of COPD in the broader general population internationally. Seven databases were searched for studies involving adults from the general public without a COPD diagnosis or clinical expertise. Eligible studies assessed awareness of COPD (existence of the condition), with a secondary aim of synthesizing data on disease-pertinent knowledge (e.g., symptoms and risk factors). Nineteen studies from ten countries across low-, middle-, and high-income settings were included. Awareness of COPD was consistently poor, regardless of the socioeconomic status of the country of study. There was similarly suboptimal knowledge of symptoms, signs, and most risk factors of the disease, apart from smoking, which was consistently recognized as a key risk factor for COPD. Younger age was the only factor frequently associated with greater disease awareness, but results should be interpreted with caution. Social media and television were the main sources of COPD information, followed by clinician and family/friend sources. Public awareness and knowledge of COPD remain suboptimal globally and should be prioritized to support disease prevention and early intervention. Policymakers should harness social media and television fora to disseminate key information about COPD to the general public and vulnerable groups therein.